Kidney Care Community News

RenalytixAI and DaVita are collaborating on a program that will use an artificial intelligence-based diagnostic tool to aid in identifying individuals at risk for kidney disease or kidney failure.

KidneyX has set a Jan. 20 deadline for submissions to Round 2 of the COVID-19 Kidney Care Challenge.

Jeffrey Goffman has been named CEO of nonprofit dialysis provider Satellite Healthcare.

U.S. Renal Care announced it is in the process of obtaining bamlanivimab, a monoclonal antibody therapy that has received emergency use authorization by the FDA for the treatment of mild-to-moderate COVID-19.

Cara Therapeutics has submitted a new drug application to the FDA for its injectable form of difelikefalin, a medication designed to treat moderate-to-severe pruritus in patients on hemodialysis.

The National Kidney Foundation has released a statement urging the federal government to grant priority to patients with kidney disease and their contacts for receipt of COVID-19 vaccines.

Data from Italy indicate the impact of COVID-19 is not greater for children with chronic kidney disease or immunosuppression compared with a pediatric cohort who have neither condition.

Findings from the 2018 Global Kidney Health Atlas survey showed that although conservative management for kidney disease is available in most countries, the quality and accessibility of care varies.

Kidney Disease: Improving Global Outcomes is prioritizing its evidence-based guidelines, expanding the guideline development process “to include more frequent and rapid updates,” according to a press release.

Medtronic Inc. has announced the commercial launch of its pediatric emergency dialysis device, which is indicated for use in patients weighing between 5.5 and 22 pounds who experience AKI or fluid overload.